{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:33:06Z","timestamp":1788247986520,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["CTQ2017-88179-P AEI\/ FEDER"],"award-info":[{"award-number":["CTQ2017-88179-P AEI\/ FEDER"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ejps.2020.105305","type":"journal-article","created":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T02:47:49Z","timestamp":1584154069000},"page":"105305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Potentiometric CheqSol and standardized shake-flask solubility methods are complimentary tools in physicochemical profiling"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7133-5276","authenticated-orcid":false,"given":"Diego","family":"Lucero-Borja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3245-5088","authenticated-orcid":false,"given":"Xavier","family":"Subirats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Barbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafel","family":"Prohens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Avdeef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7811-986X","authenticated-orcid":false,"given":"Clara","family":"R\u00e0fols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2020.105305_bib0001","unstructured":"ACD\/Labs. Advanced Chemistry Development, Inc. Toronto, ON, Canada, 2019."},{"key":"10.1016\/j.ejps.2020.105305_bib0002","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2020.105305_bib0003","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5599\/admet.505","article-title":"Cocrystal solubility-pH and drug solubilization capacity of sodium dodecyl sulfate\u2013mass action model for data analysis and simulation to improve design of experiments","volume":"6","author":"Avdeef","year":"2018","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.ejps.2020.105305_bib0004","doi-asserted-by":"crossref","first-page":"298","DOI":"10.5599\/admet.3.4.259","article-title":"Solubility temperature dependence predicted from 2D structure","volume":"3","author":"Avdeef","year":"2015","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.ejps.2020.105305_bib0005","series-title":"Absorption and Drug Development: Solubility, Permeability, and Charge State","article-title":"Absorption and drug development","author":"Avdeef","year":"2012"},{"key":"10.1016\/j.ejps.2020.105305_bib0006","series-title":"Molecular Drug Properties: Measurement and Prediction","first-page":"53","article-title":"Drug ionization and physicochemical profiling","author":"Avdeef","year":"2008"},{"key":"10.1016\/j.ejps.2020.105305_bib0007","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.addr.2007.05.008","article-title":"Solubility of sparingly-soluble ionizable drugs","volume":"59","author":"Avdeef","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2020.105305_bib0008","first-page":"165","article-title":"pH-metric solubility. 1. Solubility-pH profiles from Bjerrum plots. Gibbs buffer and pK(a) in the solid state","volume":"4","author":"Avdeef","year":"1998","journal-title":"Pharm. Pharmacol. Commun."},{"key":"10.1016\/j.ejps.2020.105305_bib0009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1007526826979","article-title":"pH-metric solubility. 2: Correlation between the acid-base titration and the saturation shake-flask solubility-pH methods","volume":"17","author":"Avdeef","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2020.105305_bib0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/ac00049a010","article-title":"pH-Metric log P. 3. Glass electrode calibration in methanol-water, applied to pKa determination of water-insoluble substances","volume":"65","author":"Avdeef","year":"1993","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejps.2020.105305_bib0011","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5599\/admet.4.2.292","article-title":"Equilibrium solubility measurement of ionizable drugs\u2013consensus recommendations for improving data quality","volume":"4","author":"Avdeef","year":"2016","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.ejps.2020.105305_bib0012","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1021\/jm0706416","article-title":"Poorly soluble marketed drugs display solvation limited solubility","volume":"50","author":"Bergstr\u00f6m","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2020.105305_bib0013","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/jps.22799","article-title":"A discriminating dissolution method for glimepiride polymorphs","volume":"101","author":"Bonfilio","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105305_bib0014","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/cbdv.200900164","article-title":"New ideas about the solubility of drugs","volume":"6","author":"Box","year":"2009","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejps.2020.105305_bib0015","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/jps.20613","article-title":"Equilibrium versus kinetic measurements of aqueous solubility, and the ability of compounds to supersaturate in solution\u2014a validation study","volume":"95","author":"Box","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105305_bib0016","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.drudis.2011.11.007","article-title":"Bridging solubility between drug discovery and development","volume":"17","author":"Di","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2020.105305_bib0018","first-page":"281","article-title":"Polymorphism of glimepiride: crystallographic study, thermal transitions behavior and dissolution study","volume":"13","author":"Endo","year":"2003","journal-title":"STP Pharma Sci."},{"key":"10.1016\/j.ejps.2020.105305_bib0017","unstructured":"EMA, 2018. ICH guideline M9 on biopharmaceutics classification system based biowaivers\u2013Step 2b\u2013First version. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-m9-biopharmaceutics-classification-system-based-biowaivers-step-2b-first-version_en.pdf (Accessed 9.23.19)."},{"key":"10.1016\/j.ejps.2020.105305_bib0020","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1039\/C3CS60451A","article-title":"Pre-nucleation clusters as solute precursors in crystallisation","volume":"43","author":"Gebauer","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejps.2020.105305_bib0021","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1021\/je900546z","article-title":"A contribution to the glimepiride dissociation constant determination","volume":"55","author":"Grbic","year":"2010","journal-title":"J. Chem. Eng. Data"},{"key":"10.1016\/j.ejps.2020.105305_bib0022","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1021\/jm9810349","article-title":"Repaglinide and related hypoglycemic benzoic acid derivatives","volume":"41","author":"Grell","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2020.105305_bib0023","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1107\/S0108768111002412","article-title":"Charge-density analysis in polymorphs of urea\u2013barbituric acid co-crystals","volume":"67","author":"Gryl","year":"2011","journal-title":"Acta Crystallogr. Sect. B Struct. Sci."},{"key":"10.1016\/j.ejps.2020.105305_bib0019","unstructured":"FDA, 2017. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. https:\/\/www.fda.gov\/media\/70963\/download (Accessed 9.23.19)."},{"key":"10.1016\/j.ejps.2020.105305_bib0024","unstructured":"in-ADME Research. New York City, USA, 2019."},{"key":"10.1016\/j.ejps.2020.105305_bib0025","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.1021\/acs.jmedchem.5b01105","article-title":"An aggregation advisor for ligand discovery","volume":"58","author":"Irwin","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2020.105305_bib0026","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1107\/S0108270196002363","article-title":"Glimepiride","volume":"53","author":"Iwata","year":"1997","journal-title":"Acta Crystallogr. Sect. C Cryst. Struct. Commun."},{"key":"10.1016\/j.ejps.2020.105305_bib0027","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ejps.2019.03.014","article-title":"Solubility-pH profile of desipramine hydrochloride in saline phosphate buffer: enhanced solubility due to drug\u2013buffer aggregates","volume":"133","author":"Markovi\u0107","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105305_bib0028","first-page":"532","article-title":"Kinetic and intrinsic solubility determination of some b-blockers and antidiabetics by potentiometry","volume":"4","author":"Narasimham","year":"2011","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.ejps.2020.105305_bib0029","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejpb.2015.02.028","article-title":"Characterisation of selected active agents regarding pKa values, solubility concentrations and pH profiles by SiriusT3","volume":"92","author":"Sch\u00f6nherr","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2020.105305_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/10837450802498894","article-title":"Co-solvent solubilization of some poorly-soluble antidiabetic drugs","volume":"14","author":"Seedher","year":"2009","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2020.105305_bib0031","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1208\/s12249-008-9057-5","article-title":"Micellar solubilization of some poorly soluble antidiabetic drugs: a technical note","volume":"9","author":"Seedher","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2020.105305_bib0032","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejps.2012.10.028","article-title":"Solubility-pH profiles of some acidic, basic and amphoteric drugs","volume":"48","author":"Shoghi","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105305_bib0033","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1021\/ac048767n","article-title":"Chasing equilibrium: measuring the intrinsic solubility of weak acids and bases","volume":"77","author":"Stuart","year":"2005","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejps.2020.105305_bib0034","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1208\/s12248-014-9646-z","article-title":"Effect of excipients on the particle size of precipitated pioglitazone in the gastrointestinal tract: impact on bioequivalence","volume":"16","author":"Sugita","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2020.105305_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0003-2670(01)00810-8","article-title":"Multi-wavelength spectrophotometric determination of acid dissociation constants: a validation study","volume":"434","author":"Tam","year":"2001","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ejps.2020.105305_bib0036","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejps.2017.06.011","article-title":"In vivo analysis of supersaturation\/precipitation\/absorption behavior after oral administration of pioglitazone hydrochloride salt; determinant site of oral absorption","volume":"106","author":"Tanaka","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105305_bib0037","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejpb.2012.11.027","article-title":"New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone\/glimepiride and ezetimibe\/simvastatin","volume":"84","author":"Taupitz","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2020.105305_bib0038","article-title":"Method for preparing glimepiride \u03b1 crystal form","author":"Tian","year":"2017","journal-title":"Faming Zhuanli Shenqing."},{"key":"10.1016\/j.ejps.2020.105305_bib0039","article-title":"\u03b2 Crystal form of glimepiride and preparation method thereof","author":"Tian","year":"2017","journal-title":"Faming Zhuanli Shenqing."},{"key":"10.1016\/j.ejps.2020.105305_bib0040","article-title":"Method for preparing glimepiride \u03b4 crystal form","author":"Tian","year":"2017","journal-title":"Faming Zhuanli Shenqing."},{"key":"10.1016\/j.ejps.2020.105305_bib0041","article-title":"Preparation of glimepiride crystal form \u03b5","author":"Tian","year":"2017","journal-title":"Faming Zhuanli Shenqing."},{"key":"10.1016\/j.ejps.2020.105305_bib0042","article-title":"Glimepiride \u03b3 crystal form and preparation method thereof","author":"Tian","year":"2017","journal-title":"Faming Zhuanli Shenqing."},{"key":"10.1016\/j.ejps.2020.105305_bib0043","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1080\/03639045.2019.1665062","article-title":"A review of methods for solubility determination in biopharmaceutical drug characterization","volume":"45","author":"Veseli","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2020.105305_bib0044","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5599\/admet.1.4.24","article-title":"Salt solubility products of diprenorphine hydrochloride, codeine and lidocaine hydrochlorides and phosphates\u2013novel method of data analysis not dependent on explicit solubility equations","volume":"1","author":"V\u00f6lgyi","year":"2013","journal-title":"ADMET DMPK"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720300944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720300944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:55:56Z","timestamp":1778558156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098720300944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":44,"alternative-id":["S0928098720300944"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105305","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potentiometric CheqSol and standardized shake-flask solubility methods are complimentary tools in physicochemical profiling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105305"}}